174 related articles for article (PubMed ID: 33816238)
1. Exosomal LncRNA LBX1-AS1 Derived From RBPJ Overexpressed-Macrophages Inhibits Oral Squamous Cell Carcinoma Progress
Ai Y; Wei H; Wu S; Tang Z; Li X; Zou C
Front Oncol; 2021; 11():605884. PubMed ID: 33816238
[TBL] [Abstract][Full Text] [Related]
2. Exosomal hsa_circ_0004658 derived from RBPJ overexpressed-macrophages inhibits hepatocellular carcinoma progression via miR-499b-5p/JAM3.
Zhang L; Zhang J; Li P; Li T; Zhou Z; Wu H
Cell Death Dis; 2022 Jan; 13(1):32. PubMed ID: 35013102
[TBL] [Abstract][Full Text] [Related]
3. Exosomal circRNA BTG2 derived from RBP-J overexpressed-macrophages inhibits glioma progression via miR-25-3p/PTEN.
Shi L; Cao Y; Yuan W; Guo J; Sun G
Cell Death Dis; 2022 May; 13(5):506. PubMed ID: 35643814
[TBL] [Abstract][Full Text] [Related]
4. LncRNA DS Cell Adhesion Molecule Antisense RNA 1 Facilitates Oral Squamous Cell Carcinoma Progression through The microRNA-138-5p/ Enhancer of Zeste 2 Polycomb Repressive Complex 2 Subunit Axis.
Zhang Y; Wang X; Wang P; Zhang X; Han SH; Huo F
Cell J; 2022 May; 24(5):222-229. PubMed ID: 35717565
[TBL] [Abstract][Full Text] [Related]
5. LncRNA MCM3AP-AS1 promotes proliferation, migration and invasion of oral squamous cell carcinoma cells via regulating miR-204-5p/FOXC1.
Li H; Jiang J
J Investig Med; 2020 Oct; 68(7):1282-1288. PubMed ID: 32690597
[TBL] [Abstract][Full Text] [Related]
6. Down-regulated lncRNA SBF2-AS1 in M2 macrophage-derived exosomes elevates miR-122-5p to restrict XIAP, thereby limiting pancreatic cancer development.
Yin Z; Zhou Y; Ma T; Chen S; Shi N; Zou Y; Hou B; Zhang C
J Cell Mol Med; 2020 May; 24(9):5028-5038. PubMed ID: 32301277
[TBL] [Abstract][Full Text] [Related]
7. Macrophages-derived exosomal lncRNA LIFR-AS1 promotes osteosarcoma cell progression via miR-29a/NFIA axis.
Zhang H; Yu Y; Wang J; Han Y; Ren T; Huang Y; Chen C; Huang Q; Wang W; Niu J; Lou J; Guo W
Cancer Cell Int; 2021 Apr; 21(1):192. PubMed ID: 33794884
[TBL] [Abstract][Full Text] [Related]
8. Exosomal lncRNA CHL1-AS1 Derived from Peritoneal Macrophages Promotes the Progression of Endometriosis via the miR-610/MDM2 Axis.
Liu T; Liu M; Zheng C; Zhang D; Li M; Zhang L
Int J Nanomedicine; 2021; 16():5451-5464. PubMed ID: 34408418
[TBL] [Abstract][Full Text] [Related]
9. Exosomal-mediated transfer of APCDD1L-AS1 induces 5-fluorouracil resistance in oral squamous cell carcinoma via miR-1224-5p/nuclear receptor binding SET domain protein 2 (NSD2) axis.
Li S; Shi Z; Fu S; Li Q; Li B; Sang L; Wu D
Bioengineered; 2021 Dec; 12(1):7188-7204. PubMed ID: 34546854
[TBL] [Abstract][Full Text] [Related]
10. MSC-derived exosomes promote proliferation and inhibit apoptosis of chondrocytes via lncRNA-KLF3-AS1/miR-206/GIT1 axis in osteoarthritis.
Liu Y; Lin L; Zou R; Wen C; Wang Z; Lin F
Cell Cycle; 2018; 17(21-22):2411-2422. PubMed ID: 30324848
[TBL] [Abstract][Full Text] [Related]
11. Osteosarcoma Cell-Derived Exosomal ELFN1-AS1 Mediates Macrophage M2 Polarization
Wang B; Wang X; Li P; Niu X; Liang X; Liu G; Liu Z; Ge H
Front Oncol; 2022; 12():881022. PubMed ID: 35785218
[TBL] [Abstract][Full Text] [Related]
12. Mechanism of lncRNA FEZF1-AS1 in promoting the occurrence and development of oral squamous cell carcinoma through targeting miR-196a.
Xu L; Hou TJ; Yang P
Eur Rev Med Pharmacol Sci; 2019 Aug; 23(15):6505-6515. PubMed ID: 31378890
[TBL] [Abstract][Full Text] [Related]
13. A novel lncRNA MCM3AP-AS1 promotes the growth of hepatocellular carcinoma by targeting miR-194-5p/FOXA1 axis.
Wang Y; Yang L; Chen T; Liu X; Guo Y; Zhu Q; Tong X; Yang W; Xu Q; Huang D; Tu K
Mol Cancer; 2019 Feb; 18(1):28. PubMed ID: 30782188
[TBL] [Abstract][Full Text] [Related]
14. LncRNA INHBA-AS1 promotes cell growth, migration, and invasion of oral squamous cell carcinoma by sponging miR-143-3p.
Ma WQ; Chen J; Fang W; Yang XQ; Zhu A; Zhang D; Zhong HL; Yang B; Luo Z
Eur Rev Med Pharmacol Sci; 2020 Feb; 24(4):1821-1828. PubMed ID: 32141551
[TBL] [Abstract][Full Text] [Related]
15. Exosomal lncRNA RAMP2-AS1 Derived from Chondrosarcoma Cells Promotes Angiogenesis Through miR-2355-5p/VEGFR2 Axis.
Cheng C; Zhang Z; Cheng F; Shao Z
Onco Targets Ther; 2020; 13():3291-3301. PubMed ID: 32368088
[TBL] [Abstract][Full Text] [Related]
16. lncRNA MCM3AP-AS1 promotes the development of oral squamous cell carcinoma by inhibiting miR-363-5p.
Hou C; Wang X; Du B
Exp Ther Med; 2020 Aug; 20(2):978-984. PubMed ID: 32742341
[TBL] [Abstract][Full Text] [Related]
17. LncRNA LHFPL3-AS1 Promotes Oral Squamous Cell Carcinoma Growth and Cisplatin Resistance Through Targeting miR-362-5p/CHSY1 Pathway.
Li J; Xu X; Zhang D; Lv H; Lei X
Onco Targets Ther; 2021; 14():2293-2300. PubMed ID: 33833527
[TBL] [Abstract][Full Text] [Related]
18. Long Noncoding RNA ZEB1-AS1 Downregulates miR-23a, Promotes Tumor Progression, and Predicts the Survival of Oral Squamous Cell Carcinoma Patients.
Wang X; Guo Y; Wang C; Wang Q; Yan G
Onco Targets Ther; 2021; 14():2699-2710. PubMed ID: 33888994
[TBL] [Abstract][Full Text] [Related]
19. lncRNA TMEM161B-AS1 screened the onset of oral squamous cell carcinoma in HPV-infected patients, predicted poor prognosis, and regulated cell progression via modulating the miR-651-5p/BDNF axis.
Wang M; Han Z; Wang X; Cheng Y; Cao Z; Zhang Y; Zhang Y
Odontology; 2024 Feb; ():. PubMed ID: 38376795
[TBL] [Abstract][Full Text] [Related]
20. COX10-AS1-mediated miR-361-5p regulated cell invasion and migration by targeting SPRY1 in oral squamous cell carcinoma.
Deng J; Wu M
Am J Transl Res; 2023; 15(3):2191-2206. PubMed ID: 37056821
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
